These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18174288)

  • 1. Insulin-like growth factor-i regulates Kruppel-like factor-6 gene expression in a p53-dependent manner.
    Bentov I; Narla G; Schayek H; Akita K; Plymate SR; LeRoith D; Friedman SL; Werner H
    Endocrinology; 2008 Apr; 149(4):1890-7. PubMed ID: 18174288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.
    Rubinstein M; Idelman G; Plymate SR; Narla G; Friedman SL; Werner H
    Endocrinology; 2004 Aug; 145(8):3769-77. PubMed ID: 15131018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells.
    Gehrau RC; D'Astolfo DS; Andreoli V; Bocco JL; Koritschoner NP
    Mutat Res; 2011 Feb; 707(1-2):15-23. PubMed ID: 21147133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.
    Chiam K; Ryan NK; Ricciardelli C; Day TK; Buchanan G; Ochnik AM; Murti K; Selth LA; ; Butler LM; Tilley WD; Bianco-Miotto T
    Prostate; 2013 Jan; 73(2):182-93. PubMed ID: 22782870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kruppel-like factor 6 (KLF6) affects the promoter activity of the alpha1-proteinase inhibitor gene.
    Chiambaretta F; Nakamura H; De Graeve F; Sakai H; Marceau G; Maruyama Y; Rigal D; Dastugue B; Sugar J; Yue BY; Sapin V
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):582-90. PubMed ID: 16431954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid and its metabolites modulate IGF-I receptor gene expression in colon cancer cells in a p53-dependent manner.
    Attias Z; Werner H; Vaisman N
    Endocr Relat Cancer; 2006 Jun; 13(2):571-81. PubMed ID: 16728583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
    Andreoli V; Gehrau RC; Bocco JL
    IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF6: mutational analysis and effect on cancer cell proliferation.
    Yin D; Komatsu N; Miller CW; Chumakov AM; Marschesky A; McKenna R; Black KL; Koeffler HP
    Int J Oncol; 2007 Jan; 30(1):65-72. PubMed ID: 17143513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
    Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
    Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
    Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.
    Ohlsson C; Kley N; Werner H; LeRoith D
    Endocrinology; 1998 Mar; 139(3):1101-7. PubMed ID: 9492043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like factor 6 interferes with cellular transformation induced by the H-ras oncogene.
    Trucco LD; Andreoli V; Núñez NG; Maccioni M; Bocco JL
    FASEB J; 2014 Dec; 28(12):5262-76. PubMed ID: 25212220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
    Werner H; Maor S
    Trends Endocrinol Metab; 2006 Aug; 17(6):236-42. PubMed ID: 16815029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.
    DiFeo A; Narla G; Hirshfeld J; Camacho-Vanegas O; Narla J; Rose SL; Kalir T; Yao S; Levine A; Birrer MJ; Bonome T; Friedman SL; Buller RE; Martignetti JA
    Clin Cancer Res; 2006 Jun; 12(12):3730-9. PubMed ID: 16778100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.